Lansoloc

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

113 API Suppliers, 40 USDMF, 26 CEP/COS, 18 JDMF, 19 EU WC, 18 KDMF, 21 NDC API, 52 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

41 Drugs in Development

41 Drugs in Development

INTERMEDIATES

22 Intermediate Suppliers

22 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

775 FDF Dossiers, 68 FDA Orange Book, 462 Europe, 27 Canada, 59 Australia, 37 South Africa, 122 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED REL PELLETS;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 30MG, CAPSULE, DELAYED REL PELLETS;ORAL - 15MG, CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 8 Evonik, 7 Rochem International Inc, 23 SPI Pharma, 13 DKSH, 1 Pharm-RX Chemical, 2 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 8 Kirsch Pharma, 4 ACG Worldwide, 10 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 26 BASF, 1 Bioplus Life Sciences, 3 CD Formulation, 2 Clariant, 14 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 3 Finar, 10 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 12 Ideal Cures, 4 Ingredion Pharma Solutions, 20 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 40 Roquette, 16 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

84 Fillers, Diluents & Binders, 71 Coating Systems & Additives, 47 Thickeners and Stabilizers, 39 Taste Masking, 37 Solubilizers, 37 Controlled & Modified Release, 35 Direct Compression, 28 Film Formers & Plasticizers, 27 Granulation, 27 Parenteral, 25 Topical, 23 Disintegrants & Superdisintegrants, 23 Lubricants & Glidants, 22 Chewable & Orodispersible Aids, 15 Co-Processed Excipients, 12 Emulsifying Agents, 10 Surfactant & Foaming Agents, 9 Rheology Modifiers, 9 Empty Capsules, 7 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

214 News #PharmaBuzz

214 News #PharmaBuzz

GLOBAL SALES INFORMATION

17 US Medicaid Prescriptions, 408 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

20 APIs, 10 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 17 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 18 Others

ANALYTICAL

1 BioAnalytical Methods, 4 Analytical Methods

$ Xls

Filters

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Amarin to Present REDUCE-IT® and EPA Data at ESC Congress 2025

25 Aug 2025

// GLOBENEWSWIRE

Amarin Announces Q2 2025 Financial Results

30 Jul 2025

// GLOBENEWSWIRE

Amarin to Announce Q2 2025 Financial Results, Host Conference

23 Jul 2025

// GLOBENEWSWIRE

Amarin licenses Vazkepa to Recordati for Europe

24 Jun 2025

// GLOBENEWSWIRE

Amarin Reports First Quarter 2025 Financial Results

07 May 2025

// GLOBENEWSWIRE

Amarin complies with Nasdaq bid price Rule

29 Apr 2025

// GLOBENEWSWIRE

Lansoloc

Lansoloc

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

113 API Suppliers

40 USDMF

26 CEP/COS

18 JDMF

19 EU WC

18 KDMF

21 NDC API

52 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

41 Drugs in Development

INTERMEDIATES

22 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

775 FDF Dossiers

68 FDA Orange Book

462 Europe

27 Canada

59 Australia

37 South Africa

122 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED REL PELLETS;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 30MG

CAPSULE, DELAYED REL PELLETS;ORAL - 15MG

CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

8 Evonik

7 Rochem International Inc

23 SPI Pharma

13 DKSH

1 Pharm-RX Chemical

2 Boai NKY Pharmaceuticals Ltd

8 Gangwal Healthcare

9 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

8 Kirsch Pharma

4 ACG Worldwide

10 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Avesta Pharma

26 BASF

1 Bioplus Life Sciences

3 CD Formulation

2 Clariant

14 Corel Pharma Chem

5 DFE Pharma

3 Doshion Polyscience

1 Esteem Industries

3 Finar

10 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

12 Ideal Cures

4 Ingredion Pharma Solutions

20 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

1 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

3 Pharmatrans-Sanaq

7 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

40 Roquette

CAPSULE, DELAYED REL PELLETS;ORAL - 15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons